RESMED/IDR UNRESTR (ASX:RMD)’s share price passed below its fifty day moving average during trading on Monday . The stock has a fifty day moving average of $19.03 and traded as low as $19.80. RESMED/IDR UNRESTR shares last traded at $19.91, with a volume of 1,168,953 shares.
The company has a debt-to-equity ratio of 61.33, a current ratio of 2.06 and a quick ratio of 1.23. The business’s 50 day moving average price is A$19.20 and its 200-day moving average price is A$16.49. The firm has a market capitalization of $28.72 billion and a price-to-earnings ratio of 71.54.
The company also recently declared a Final dividend, which was paid on Thursday, September 19th. Stockholders of record on Thursday, September 19th were paid a dividend of $0.039 per share. The ex-dividend date was Wednesday, August 14th. This represents a dividend yield of 0.21%. RESMED/IDR UNRESTR’s dividend payout ratio (DPR) is 82.14%.
ResMed Inc develops, manufactures, distributes, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders comprising sleep disordered breathing, chronic obstructive pulmonary disease, neuromuscular disease, and other chronic diseases. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, portable oxygen concentrators, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes.
Further Reading: What is a Buy-Side Analyst?
Receive News & Ratings for RESMED/IDR UNRESTR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RESMED/IDR UNRESTR and related companies with MarketBeat.com's FREE daily email newsletter.